跳到主要內容

Nader Francois 的 Form 4/A 修正申報

修正

Tourmaline Bio, Inc.TRML,2022/9/13 申報

申報編號
0000899243-22-030924
申報時間
2022/9/13
交易日
2022/7/19-7/25
申報延遲
56 天
10b5-1 計畫
表單沒有這欄(2023 年以前)
原始申報日
2022/7/25

這份申報列了 7 筆非衍生性交易。公開市場買進合計 $50.0 萬。交易後 56 天申報。

這份修正申報取代了 0000899243-22-026684(2022/7/25 申報)。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Nader FrancoisCIK 0001365343董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/7/19Common StockP買進取得+50,000$3.52F1+$176,00050,000直接
2022/7/20Common StockP買進取得+52,000$3.62F2+$188,240102,000直接
2022/7/21Common StockJ其他處分−248,432$0.00$0147,255間接
2022/7/21Common StockJ其他取得+248,432$0.00$0248,432間接
2022/7/21Common StockP買進取得+36,500$3.72F6+$135,780138,500直接
2022/7/25Common StockJ其他處分−138,500$0.00$00直接
2022/7/25Common StockJ其他取得+138,500$0.00$0386,932間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.38 to $3.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.51 to $3.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents the transfer of shares held by the Francois Nader 2020 Trust to FN TALS LLC for no consideration.

F4

These shares are held in a trust for the benefit of the Reporting Person's spouse and child. The Reporting Person''s spouse and child are trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F5

These shares are held by a limited liability company of which the Reporting Person serves as the sole member, with sole voting and investment control over the securities held thereby. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F6

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.595 to $3.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents the transfer of shares held by the Reporting Person to FN TALS LLC for no consideration.

F8

This amendment is being filed solely to correct the number of shares reported by the Francois Nader 2020 Trust, which was incorrectly reported due to an administrative error.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)